Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-004578

Chief Executive Officer acquired 11,205 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Carpenter George C IV · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-25 Grant or award : show line 1 in the form +11,205 $2.27 $25,435 50,913 D
Loading xslF345X03/s110524_form4.xml…